Recently, PRIM&R submitted comments to the International Committee of Medical Journal Editors (ICMJE) in response to their proposed requirements for sharing clinical trial data. PRIM&R stated that we fully support initiatives to promote data sharing on the grounds it enhances the value of clinical research and the participation of human research subjects. Read more
TAG ARCHIVES FOR data sharing
This week’s Research Ethics Roundup explores new developments for researchers who work with animal models, a new Institute of Medicine report on Agent Orange, and how scholars are reacting to the latest data sharing requirements. Read more
This week’s Research Ethics Roundup examines the National Institutes of Health’s (NIH) decision to host a workshop on using monkeys in research, a new BMJ study on academic institutions that are not reporting to ClinicalTrials.gov, and two editorials on government initiatives in the United States and the United Kingdom.
Safety First: In this editorial, Nature states their concern that some federal departments have still not complied with a Presidential Commission for the Study of Bioethical Issues’ request that basic data about departmental work with human subjects be publicly available. Nature [...] Read more
While many agree that increased data sharing is an ethical imperative given the risks that clinical trial participants are asked to undertake, the question many institutions are now struggling with is how they can meet that imperative with their current resources and while protecting the privacy of study subjects. Read more
By Samia Rizk, MD, professor of clinical pathology at Cairo University
Open data refers to “data that can be freely used, shared, and built-on by anyone, anywhere.” Data which is considered “open” is further required to be legally acceptable, technically readable, and available to others. The many potential benefits attributed to data sharing are combined with its many challenges: assuring privacy and security, the autonomy of participants as it relates to their ability to give valid consent, population and cultural issues, measures for appropriate governance, commercialization, and sustainability of databases.
With no binding requirement, it is a scientist’s decision whether or [...] Read more